Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
UTI Healthcare Fund (G) Direct |
[Equity: Sectoral] |
|
|
|
|
Instruments Breakdown |
Instruments |
Composition |
Current Asset |
1.66 |
Equity |
98.17 |
GOI Securities |
0.16 |
Term Deposits |
0.01 |
|
|
Concentration Analysis |
Top 5 Holdings |
39.87% |
Top 10 Holdings |
59.37% |
Top 25 Holdings |
91.34% |
|
|
|
|
Sector Analysis |
Sector/Ratings |
Net Asset(%) |
Pharma & Biotech |
76.93 |
Healthcare |
20.58 |
Cash |
1.66 |
Miscellaneous |
0.66 |
SOV |
0.16 |
Others |
0.01 |
|
|
|
|
Portfolio Metrics |
|
PB Ratio |
4.61 |
PE Ratio |
35.36 |
|
|
Top 25 Holdings |
|
Holdings |
Net Asset(%) |
Sun Pharmaceutical Industries Limited |
12.60 |
Cipla Limited |
8.91 |
Dr Reddys Laboratories Limited |
7.13 |
Apollo Hospitals Enterprise Limited |
5.89 |
Ajanta Pharma Limited |
5.34 |
Fortis Health Care Ltd |
4.34 |
Aurobindo Pharma Limited |
4.31 |
Krishna Inst of Medical Sciences Ltd. |
4.12 |
DIVI LABORATORIES LTD |
3.52 |
Eris Lifesciences Limited |
3.21 |
Suven Pharmaceuticals Limited |
3.20 |
Torrent Pharmaceuticals Limited |
3.09 |
IPCA Laboratories Limited |
2.93 |
Zydus Lifesciences Limited |
2.74 |
Gland Pharma Limited |
2.69 |
Procter & Gamble Health Limited |
2.14 |
Metropolis Healthcare Limited |
2.07 |
Alkem Laboratories Limited |
2.02 |
Concord Biotech Limited |
1.94 |
Ami Organics Limited |
1.70 |
NET CURRENT ASSETS |
1.66 |
Poly Medicure Limited |
1.60 |
Syngene International Limited |
1.47 |
Biocon Limited |
1.43 |
MANKIND PHARMA LIMITED |
1.29 |
|
|
|
|
|
|
Sector Analysis Graphical Mode |
|
|
|
|
|
|
 |
|
|
|
|